This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
The Estee Lauder Companies (EL) & BALMAIN to Launch a Beauty Line
by Zacks Equity Research
The Estee Lauder Companies (EL) signs a license agreement with BALMAIN to introduce BALMAIN BEAUTY. The collaboration is likely to launch in fall 2024.
Here is Why Growth Investors Should Buy e.l.f. Beauty (ELF) Now
by Zacks Equity Research
e.l.f. Beauty (ELF) possesses solid growth attributes, which could help it handily outperform the market.
COTY Pulls Up Q1 View on Solid Demand for Beauty & Skin Care
by Zacks Equity Research
COTY is seeing solid beauty demand in the near term, pushing management to raise its first-quarter fiscal 2023 view. It expects to double skincare revenues by fiscal 2025.
e.l.f. Beauty (ELF) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
e.l.f. Beauty (ELF) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Philip Morris (PM) Benefits From Focus on RRPs & Pricing Power
by Zacks Equity Research
Philip Morris (PM) is well placed to become a majority smoke-free company by 2025. The company has long been benefiting from its strong pricing power.
Has e.l.f. Beauty (ELF) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how e.l.f. Beauty (ELF) and Lancaster Colony (LANC) have performed compared to their sector so far this year.
Helen of Troy (HELE) Down More Than 45% in 6 Months: Here's Why
by Zacks Equity Research
Helen of Troy (HELE) is battling headwinds like a shift in consumer buying patterns, inflation, supply-chain disruptions and unfavorable currency.
The Estee Lauder Companies (EL) Online Business Aids Growth
by Zacks Equity Research
The Estee Lauder Companies (EL) online operations and Skin Care business bode well. However, the company is witnessing inflation and supply chain disruptions.
COTY Poised on Strategic Pillars & Cost Saving Efforts
by Zacks Equity Research
COTY is benefiting from its focus on six strategic pillars aimed at sustainable growth. Management is on track to mitigate the impact of inflation via cost savings.
Nu Skin (NUS) Down More Than 15% in 3 Months: Here's Why
by Zacks Equity Research
Nu Skin (NUS) is battling continued economic uncertainty, prolonged COVID-associated factors, unfavorable currency rates and geopolitical conflicts.
Looking for a Growth Stock? 3 Reasons Why e.l.f. Beauty (ELF) is a Solid Choice
by Zacks Equity Research
e.l.f. Beauty (ELF) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Has The Chef's Warehouse (CHEF) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how Chefs' Warehouse (CHEF) and e.l.f. Beauty (ELF) have performed compared to their sector so far this year.
COTY Q4 Loss In Line With Estimates, Sales Increase Y/Y
by Zacks Equity Research
COTY fourth-quarter fiscal 2022 results reflect improved top and bottom lines on growth across almost all regions and channels. Focus on strategic growth pillars is yielding.
e.l.f. Beauty (ELF) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
e.l.f. Beauty (ELF) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here's Why e.l.f. Beauty (ELF) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does e.l.f. Beauty (ELF) have what it takes to be a top stock pick for momentum investors? Let's find out.
3 Reasons Why e.l.f. Beauty (ELF) Is a Great Growth Stock
by Zacks Equity Research
e.l.f. Beauty (ELF) is well positioned to outperform the market, as it exhibits above-average growth in financials.
The Estee Lauder Companies (EL) Beats on Earnings in Q4
by Zacks Equity Research
The Estee Lauder Companies' (EL) fourth-quarter fiscal 2022 sales and earnings decline year over year on softness in almost all regions. Rising inflation and supply chain disruptions pose a threat.
Helen of Troy (HELE) Hurt by Cost Inflation, Down 24% in 3 Months
by Zacks Equity Research
Helen of Troy (HELE) is grappling with cost inflation and supply chain headwinds. It is also bearing the brunt of reduced consumer demand and shifts in consumer spending patterns.
e.l.f. Beauty (ELF) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
e.l.f. Beauty (ELF) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Clorox (CLX) Falls on Q4 Earnings & Sales Miss, Bleak View
by Zacks Equity Research
Clorox's (CLX) Q4 results reflect the impacts of lower shipments, higher tax rate and continued costs headwinds related to elevated manufacturing and logistics costs, and higher commodity costs.
E.l.f. Beauty (ELF) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
e.l.f. Beauty (ELF) delivered earnings and revenue surprises of 69.57% and 12.05%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Why e.l.f. Beauty (ELF) Could Beat Earnings Estimates Again
by Zacks Equity Research
e.l.f. Beauty (ELF) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
e.l.f. Beauty (ELF) Soars 7.5%: Is Further Upside Left in the Stock?
by Zacks Equity Research
e.l.f. Beauty (ELF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Things to Note as General Mills (GIS) Readies for Q4 Earnings
by Zacks Equity Research
General Mills' (GIS) fourth-quarter fiscal 2022 results are likely to reflect gains from the Accelerate strategy and elevated at-home demand, while cost headwinds persist.
E.l.f. Beauty (ELF) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
e.l.f. Beauty (ELF) delivered earnings and revenue surprises of 116.67% and 15.76%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?